Evidence map›Paper›PMID 25122140›Full record

ArticlePLoS computational biology2014

Construction and validation of a regulatory network for pluripotency and self-renewal of mouse embryonic stem cells.

Huilei Xu, Yen-Sin Ang, Ana Sevilla, Ihor R Lemischka, Avi Ma'ayan

Open access · goldAbstract read
In one paragraph

Article in PLoS computational biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 107 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Huilei XuDepartment of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America; Department of Developmental and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America; Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
Yen-Sin AngDepartment of Developmental and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America; Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
Ana SevillaDepartment of Developmental and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America; Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
Ihor R LemischkaDepartment of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America; Department of Developmental and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America; Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
Avi Ma'ayanDepartment of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America; Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
Icahn School of Medicine at Mount Sinai · US

Funding

Global & Systems Level Analyses of Cell Fate RegulationR01GM078465 · NIGMS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI LEMISCHKA, IHOR R · 2007 to 2015
$3.7M
Programming HematopoiesisR01HL119404 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI LEMISCHKA, IHOR R, MOORE, KATERI A. · 2014 to 2017
$1.7M
Expression2Kinases: mRNA Profiling Linked to Multiple Upstream Regulatory LayersR01GM098316 · NIGMS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MA'AYAN, AVI · 2012 to 2015
$1.3M
NHLBI NIH HHS R01 HL119404NHLBI NIH HHS R01HL119404NIGMS NIH HHS R01 GM078465NIGMS NIH HHS R01GM078465NIGMS NIH HHS R01 GM098316NIGMS NIH HHS R01GM098316
6 · The paper itself

Abstract

A 30-node signed and directed network responsible for self-renewal and pluripotency of mouse embryonic stem cells (mESCs) was extracted from several ChIP-Seq and knockdown followed by expression prior studies. The underlying regulatory logic among network components was then learned using the initial network topology and single cell gene expression measurements from mESCs cultured in serum/LIF or serum-free 2i/LIF conditions. Comparing the learned network regulatory logic derived from cells cultured in serum/LIF vs. 2i/LIF revealed differential roles for Nanog, Oct4/Pou5f1, Sox2, Esrrb and Tcf3. Overall, gene expression in the serum/LIF condition was more variable than in the 2i/LIF but mostly consistent across the two conditions. Expression levels for most genes in single cells were bimodal across the entire population and this motivated a Boolean modeling approach. In silico predictions derived from removal of nodes from the Boolean dynamical model were validated with experimental single and combinatorial RNA interference (RNAi) knockdowns of selected network components. Quantitative post-RNAi expression level measurements of remaining network components showed good agreement with the in silico predictions. Computational removal of nodes from the Boolean network model was also used to predict lineage specification outcomes. In summary, data integration, modeling, and targeted experiments were used to improve our understanding of the regulatory topology that controls mESC fate decisions as well as to develop robust directed lineage specification protocols.

Indexed as

AnimalsCell LineComputer SimulationEmbryonic Stem CellsGene Expression ProfilingGene Knockdown TechniquesGene Regulatory NetworksMicePluripotent Stem CellsReproducibility of ResultsSystems Biology

Identifiers

PMID25122140
PMCPMC4133156
OpenAlexW2078936424

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.